美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
51407-564-05	51407-564	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 10 mg/1	500 TABLET in 1 BOTTLE (51407-564-05)
51407-564-90	51407-564	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 10 mg/1	90 TABLET in 1 BOTTLE (51407-564-90)
51407-565-05	51407-565	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 20 mg/1	500 TABLET in 1 BOTTLE (51407-565-05)
51407-565-90	51407-565	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5 mg/1; 20 mg/1	90 TABLET in 1 BOTTLE (51407-565-90)
51407-566-05	51407-566	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	25 mg/1; 20 mg/1	500 TABLET in 1 BOTTLE (51407-566-05)
51407-566-90	51407-566	HUMAN PRESCRIPTION DRUG	LISINOPRIL and HYDROCHLOROTHIAZIDE	LISINOPRIL and HYDROCHLOROTHIAZIDE	TABLET	ORAL	20250215	N/A	ANDA	ANDA076674	GSMS, Incorporated	HYDROCHLOROTHIAZIDE; LISINOPRIL	25 mg/1; 20 mg/1	90 TABLET in 1 BOTTLE (51407-566-90)